Drug level in Swiss CD1 mouse plasma treated with 5-([3,4'-Bipyridin]-2'-yl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine at 500 mg/kg,...

Basic Information

ID: ALA4019018

Type: ADME

Description: Drug level in Swiss CD1 mouse plasma treated with 5-([3,4'-Bipyridin]-2'-yl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine at 500 mg/kg, po by HPLC analysis

Format: BAO_0000218

Organism: Mus musculus

Strain: Swiss CD1

Tissue: Plasma

Target: Plasma(ALA613589)

Document: ALA4017499

Drug level in Swiss CD1 mouse plasma treated with 5-([3,4'-Bipyridin]-2'-yl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine at 500 mg/kg, po by HPLC analysis: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4019018

Drug metabolism

Total(2)

Parent Molecular Weight	ALogP	Polar Surface Area
200.20	1.84	1.84
416.49	3.21	3.21

Parent Molecular Weight

ALogP

Polar Surface Area

200.20

1.84

416.49

3.21

Drug level in Swiss CD1 mouse plasma treated with 5-([3,4'-Bipyridin]-2'-yl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine at 500 mg/kg,...

Basic Information

Activity Charts

Compound Summary